In the wake of the failed effort to repeal and replace the ACA, the fate of another of President Trump’s health care priorities is unclear: giving Americans the option to purchase health insurance across state lines, which the administration believes will increase competition and bring down costs. In their latest post, Georgetown University’s Sabrina Corlette and Kevin Lucia explain why interstate sales are unlikely to increase competition.
Selling Health Insurance Across State Lines Unlikely to Lower Costs, Improve Choice
